Sign up to save your podcasts
Or
Share E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
This week I'll discuss an important paper in systemic sclerosis, the recent SENSCIS trial that compared 150mg nitedanib to placebo. I wind up coming down pretty hard on this drug; I think it's hype has vastly outpaced its utility. Get the paper itself at ebrheum.com and follow me on @ebrheum to give feedback!
View all episodes
By Michael Putman
4.9
113113 ratings
This week I'll discuss an important paper in systemic sclerosis, the recent SENSCIS trial that compared 150mg nitedanib to placebo. I wind up coming down pretty hard on this drug; I think it's hype has vastly outpaced its utility. Get the paper itself at ebrheum.com and follow me on @ebrheum to give feedback!
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
499 Listeners
This Week in Cardiology
876 Listeners
Rheumnow Podcast
131 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
Healio Rheuminations
121 Listeners
Annals On Call Podcast
192 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
ACR on Air
67 Listeners
Run the List
247 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
Rheumatology For The Royal College
183 Listeners
RheumMadness Rheumatology Podcast
11 Listeners
ACR Journals On Air
18 Listeners
Talking Rheumatology Spotlight
6 Listeners